GOG 0277
Trial Description:
Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observtion in Treating Patients with High Risk Uterine Leiomyosarcoma Previously removed by Surgery
Lead Cooperative Group:
Participating Groups:
Trial Number:
Disease Site:
Uterine Leiomyosarcoma
Trial Status:
Completed